Additional Results from Two Randomized, Placebo-Controlled Trials of Stiripentol in Dravet Syndrome Highlight a Rapid Antiseizure Efficacy with Longer Seizure-Free Periods

Guerrini et al. (Thu,) studied this question.

www.synapsesocial.com/papers/68e6ad90b6db64358762f319 — DOI: https://doi.org/10.1007/s40120-024-00623-8

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Initiating stiripentol before 2 years of age in patients with Dravet syndrome is safe and beneficial against status epilepticus· 2023 · 23 citations
2. Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?· 2018 · 51 citations
3. Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome· 2021 · 15 citations
4. Measuring the efficacy of antiepileptic drugs· 2003 · 85 citations
5. Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy· 1998 · 464 citations